Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal type-1 receptor 2 (VN1R2) is a member of the *type 1 vomeronasal receptor (V1R)* family, which are G protein-coupled receptors (GPCRs) predominantly expressed in the vomeronasal organ—a specialized structure within the nasal cavity of many vertebrates responsible for detecting pheromonal cues and other chemosensory stimuli[1][2]. VN1R2 is involved in the recognition of sulfated estrogens, glucuronidated estrogens, and certain steroids, playing a key role in identifying steroid-derived signals in mammals[1][2]. This receptor enables social and reproductive behaviors by facilitating the nervous system’s detection of conspecific signals and physiological status through specific ligand-receptor interactions[1][2]. No direct clinical or pharmaceutical relevance has been established for this receptor, and it is primarily of interest for studies in sensory neuroscience and animal behavior[1][2].
no drug targeting VN1R2, mechanism relates to chemosensory transduction of steroidal ligands
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal type-1 receptor 2 (VN1R2).